Dechra Pharmaceuticals Manufacturing (DPM), Skipton, invests in expansion of its Liquids, Creams and Ointments (LCO) Department

pharmafile | November 12, 2013 | News story | |   

The expansion will include refurbishment of the existing building fabric, improved utilities and significant process equipment procurement. The new equipment will provide a major increase in manufacturing capability and capacity, estimated at five times the current level.

Managing Director, Mike Annice, commented ‘’Following our earlier FDA approval for solid dose production, and the recent refurbishment of our injections suite, focus is now moving to the LCO Department and a major expansion of this area will be carried out in the first half of 2014. This is another step to DPM becoming a global supplier of pharmaceutical products.’’

 

Related Content

No items found

Latest content